GlassScriptPhysician profile
Hiem Thong
NPI 1184623993
$3,914.71
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $636 · 2021: $892 · 2022: $957 · 2023: $327 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $890.37 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $353.40 | 2019-2024 | |
| Pfizer INC. | $327.96 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $287.77 | 2019-2024 | Airsupra |
| Amgen INC. | $246.19 | 2019-2023 | Repatha, Otezla |
| Abbvie INC. | $210.68 | 2021-2022 | |
| Lilly USA, LLC | $145.64 | 2020-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $144.62 | 2021-2023 | |
| Esperion Therapeutics, INC. | $134.33 | 2020-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.33 | 2019-2022 | |
| Cook Medical LLC | $123.90 | 2023 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $119.73 | 2019-2022 | |
| Astellas Pharma US INC | $81.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $77.62 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $72.79 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $57.11 | 2022-2024 | |
| Sunovion Pharmaceuticals INC. | $53.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.21 | 2019-2022 | |
| Nevro Corp. | $45.82 | 2023-2024 | Senza |
| Sanofi-Aventis U.S. LLC | $34.65 | 2019 | |
| Jazz Pharmaceuticals INC. | $33.28 | 2021 | |
| Glaxosmithkline, LLC. | $31.66 | 2019-2023 | Trelegy Ellipta |
| Eisai INC. | $30.90 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.40 | 2019-2020 | |
| Allergan, INC. | $29.38 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.34 | 2022 | |
| Pacira Therapeutics, INC. | $22.92 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.47 | 2021 | |
| Vifor Pharma, INC. | $18.04 | 2023 | Veltassa |
| Biohaven Pharmaceuticals, INC. | $17.25 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.44 | 2024 | Voquezna |
| Medtronic, INC. | $13.88 | 2023 | Minimed 780g |
| Horizon Therapeutics Plc | $13.83 | 2019 | |
| Exact Sciences Corporation | $13.61 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hiem Thong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.